UK clinical trials - updated daily from ClinicalTrials.gov
Explore clinical trials and treatment pathways for conditions across the UK. Each condition page shows treatment options, current research, and links to active trials.
HER2+, HR+, Triple Negative
NSCLC, SCLC, all subtypes
Localised to mCRPC
Leukaemia, lymphoma, myeloma
Bowel cancer, colon, rectal
PDAC, FOLFIRINOX, targeted therapy
BRCA, PARP inhibitors, HRD
HPV-related, immunotherapy
Womb cancer, MSI-H, immunotherapy
BRAF, immunotherapy, targeted therapy
Oral, throat, HPV-positive
Glioblastoma, astrocytoma, IDH
RCC, immunotherapy combinations
NMIBC, MIBC, immunotherapy
HCC, locoregional, immunotherapy
Adenocarcinoma, squamous, chemoradiation
SCLC, immunotherapy, bispecifics
Gastric, HER2+, immunotherapy
Asbestos cancer, immunotherapy, NIVO+IPI
RRMS, SPMS, PPMS, DMTs
Levodopa, DBS, neuroprotection
Anti-amyloid, lecanemab, MCI
Seizure disorder, VNS, surgery
CGRP inhibitors, Botox, chronic
Remission, GLP-1, SGLT2
Artificial pancreas, islet transplant, immunotherapy
GLP-1, Wegovy, Mounjaro, metabolic surgery
CKD, SGLT2i, dialysis, transplant
HFrEF, HFpEF, four pillars
Ischaemic, haemorrhagic, thrombectomy
AF, ablation, anticoagulation, stroke prevention
High blood pressure, renal denervation, novel agents
We have detailed treatment pathways for 40+ conditions - see the full treatment roadmap with trial opportunities at every stage.
Explore All Pathways →